Trump Killed $15M in Alzheimer's Research Because It Surveyed Black Patients

What Actually Got Killed Here

At least three grants were canceled across Emory University and the University of Pittsburgh, according to The Guardian. Researchers at both institutions were studying how discrimination, neighborhood disinvestment, and structural inequality affect long-term brain health and Alzheimer's risk. One grant examined brain white matter changes in people who experienced racial discrimination. Another studied Alzheimer's risk in predominantly Black neighborhoods that had been starved of resources. A third collected brain imaging, blood samples, and surveys to track socially driven risk factors.

These were not fringe projects. They were multi-year NIH grants using MRIs, wearable devices, blood work, and what the researchers describe, with barely contained frustration, as standard epidemiological methods. The kind of work that takes years to set up and years more to complete. The kind you can't just pause and restart like a podcast.

The Administration's Stated Reason Is Embarrassing

NIH director Dr. Jay Bhattacharya sent termination letters explaining that the projects "no longer effectuate NIH's priorities" and that "the lack of concrete, objective and measurable variables is not in alignment with NIH's priorities." The specific problem, according to multiple letters The Guardian reviewed, was that the grants included surveys and self-reported data.

Let that land for a second. Self-reported surveys are one of the foundational tools of public health research. They are used in studies on cancer, cardiovascular disease, mental health, chronic pain, and basically every other condition where patient experience matters. "What's most frustrating to me," University of Pittsburgh associate professor Ann Cohen told The Guardian, "is this assertion that our outcomes are not measurable or scientific. That demonstrates a lack of understanding of our outcomes versus our exposures. That's epidemiology 101."

The administration did not respond to The Guardian's request for comment from the Department of Health and Human Services. Shocking.

Researchers Were Left Running 'On Fumes'

This wasn't a clean cancellation. It was bureaucratic cruelty with extra steps. The Guardian reports that these same grants were frozen for months in 2025, part of the administration's broader freeze of $65 million in Alzheimer's research center funding. Researchers limped along on skeleton budgets while staff went unpaid.

Funding finally arrived in June 2026. Then came the termination notices in July. "We were running on fumes until we could get the second year of funds; those came in June, but the termination followed one month later," said Negar Fani, an associate professor of psychiatry at Emory University. The administration waited for the researchers to exhaust themselves chasing the money, then took it back. That's not bureaucratic incompetence. That's a pattern.

Andrea Rosso, a University of Pittsburgh epidemiology professor who co-led one of the canceled grants, cut to the core of it: "Whoever was doing this saw the words they didn't like in our grant."

The Legal Strategy Is as Cynical as You'd Expect

This is not the first time the Trump administration has tried to gut NIH funding on DEI grounds. The Guardian reports that in spring 2025, the administration canceled billions in federal grants with perceived DEI connections, triggering a wave of lawsuits from major research institutions. A federal judge ruled those cancellations illegal and ordered reinstatement.

Then the Supreme Court stepped in on the shadow docket, with justices voting 5-4 in an unsigned ruling to let the administration cancel $783 million in NIH funding anyway. The new round of cancellations at Emory and Pittsburgh is not covered by that litigation, which Georgetown Law professor Lawrence Gostin told The Guardian is the whole point. "The administration, particularly Secretary Kennedy, has followed a very clear pattern," Gostin said. "They do something that's clearly unlawful, they get slapped down by a federal court, and then they try to cobble together a strategy that does basically the same thing but is legally defensible."

In other words, these $15 million in grants may be test cases for a legally cleaner version of the same purge. The goal doesn't change. Only the paperwork does.

The Disease They're Refusing to Study Is Killing People

An estimated 7.4 million Americans currently live with Alzheimer's disease or dementia, according to The Guardian. The overwhelming majority of people affected are older adults, but the disease is not a normal part of aging. It is devastating, degenerative, and in most cases, fatal.

And Black Americans are twice as likely to develop it. Twice. That is not a politically motivated framing invented by researchers at Emory and Pitt. It is one of the most well-documented disparities in American medical literature. The researchers being defunded were not studying racism as an ideological exercise. They were trying to understand why one group of Americans develops a fatal brain disease at double the rate of another, because that is how you eventually figure out how to stop it.

"We don't actually measure structural racism. We use that as a framing for why one population is at such high risk," Rosso told The Guardian. "We can't come up with an intervention that's going to stop structural racism. Wish we could." That quote could double as the mission statement of the entire field. The administration's answer is to defund the question.